Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
COVID Symptoms |
Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
Recognized by America's Top Doctors, 2008, 2010 - 2018
Recognized by Best Doctors in America 2009 - 2012, 2015 - 2018
Recognized in Philadelphia magazine's 2010, 2018, and 2019 Top Docs issues
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown below from a 3rd party vendor, Press Ganey and as of 7/01/21, our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas.
Diabetes Care 37 (7): 1910-7,2014 .
Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A: Phase II trial of Vorinostat in advanced melanoma Invest New Drugs 32 (3): 526-34,2014.
Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M.: Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.
J Clin Oncol 31 (4): 412-9,2013.
Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R.: Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma J Clin Oncol 31 (2): 181-6,2013.
Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.: Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
Int J Radiat Oncol Biol Phys 83 (5): 1493-9,2012.
Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice: A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 29 (2): 761-7,2012.
Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer.
Int J Radiat Oncol Biol Phys 83 (1): 8-15,2012.
Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. International journal of radiation oncology, biology, physics 83 (1): 8-15,2012.
Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE.: Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment.
Urology : 2011.
Yeboa Debra Nana, Guzzo Thomas, Mitra Nandita, Christodouleas John P, Haas Naomi B, Vapiwala Neha, Armstrong Katrina, Bekelman Justin E: Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78 (5): 1107-13,2011.
Division of Hematology OncologyPerelman Center for Advanced Medicine10th Floor South PavilionOffice #10-1123400 Civic Center Blvd
Patient appointments: 800-789-7366